Lung Cancer Home > Tarceva and Pancreatic Cancer

When used in combination with gemcitabine, Tarceva® (erlotinib) is approved for the treatment of pancreatic cancer (cancer that begins in the tissue of the pancreas, a gland that lies behind the stomach). Specifically, Tarceva is approved for the treatment of pancreatic cancer that has advanced, spread to other areas of the body (metastasized), or cannot be removed with surgery.
(To learn more about treating pancreatic cancer with this drug, click Tarceva Uses. This article also takes an in-depth look at the other conditions Tarceva is approved to treat and includes details on how it works, who can use it, and more.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.